USP Zdrowie

USP Zdrowie is a prominent entity in the Polish over-the-counter (OTC) pharmaceutical market, established in 1991. The company specializes in health and well-being products, featuring a robust portfolio of leading brands like Ibuprom, Apap, and Gripex. With over three decades of operation, USP Zdrowie has cultivated a reputation for high product quality and efficacy, earning significant trust from consumers, patients, pharmacists, and medical professionals. Its focus on consumer health solutions positions it as a key player in the domestic healthcare sector.

Operating with 500 - 1,000 employees, USP Zdrowie maintains a significant operational footprint across two primary locations. The company's revenue reached $29.8M, underscoring its substantial market presence. Beyond commercial activities, USP Zdrowie actively supports health initiatives and operates a dedicated foundation. This foundation aims to guide individuals toward improved health outcomes, reflecting the company's broader commitment to public well-being and preventative healthcare strategies.

USP Zdrowie's sustained success is built upon trust and consistent delivery of quality healthcare products. The company's commitment to excellence is evident in its long-standing relationships with healthcare stakeholders and its continuous efforts to innovate within the OTC space. For insights into the individuals driving this mission, one can explore Meet USP Zdrowie's team. This dedication to health, combined with strategic market engagement, solidifies USP Zdrowie's position as a leader in the Polish pharmaceutical landscape, contributing to a healthier society.